Stevens Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-17,230
| Closed | -$793K | – | 169 |
|
|
2020
Q4 | $793K | Buy |
17,230
+1,024
| +6% | +$47.1K | 0.39% | 49 |
|
|
2020
Q3 | $762K | Buy |
+16,206
| New | +$762K | 0.28% | 58 |
|
|
2020
Q1 | – | Sell |
-4,821
| Closed | -$283K | – | 181 |
|
|
2019
Q4 | $283K | Buy |
4,821
+249
| +5% | +$14.6K | 0.03% | 456 |
|
|
2019
Q3 | $244K | Buy |
+4,572
| New | +$244K | 0.02% | 487 |
|
|
2018
Q4 | – | Sell |
-32,295
| Closed | -$1.62M | – | 783 |
|
|
2018
Q3 | $1.62M | Sell |
32,295
-401
| -1% | -$20.1K | 0.06% | 339 |
|
|
2018
Q2 | $1.65M | Buy |
+32,696
| New | +$1.65M | 0.06% | 352 |
|
|
2017
Q4 | – | Sell |
-6,956
| Closed | -$353K | – | 907 |
|
|
2017
Q3 | $353K | Sell |
6,956
-25,583
| -79% | -$1.3M | 0.01% | 636 |
|
|
2017
Q2 | $1.75M | Buy |
32,539
+4,746
| +17% | +$256K | 0.07% | 331 |
|
|
2017
Q1 | $1.47M | Sell |
27,793
-13,385
| -33% | -$706K | 0.06% | 355 |
|
|
2016
Q4 | $1.98M | Buy |
41,178
+35,834
| +671% | +$1.72M | 0.08% | 316 |
|
|
2016
Q3 | $288K | Buy |
+5,344
| New | +$288K | 0.01% | 715 |
|
|
2015
Q2 | – | Sell |
-17,588
| Closed | -$1.02M | – | 1102 |
|
|
2015
Q1 | $1.02M | Buy |
17,588
+5,058
| +40% | +$292K | 0.04% | 415 |
|
|
2014
Q4 | $669K | Sell |
12,530
-12,057
| -49% | -$644K | 0.02% | 508 |
|
|
2014
Q3 | $1.41M | Sell |
24,587
-18,475
| -43% | -$1.06M | 0.04% | 385 |
|
|
2014
Q2 | $2.88M | Buy |
43,062
+15,816
| +58% | +$1.06M | 0.08% | 284 |
|
|
2014
Q1 | $1.82M | Sell |
27,246
-54,086
| -67% | -$3.61M | 0.05% | 370 |
|
|
2013
Q4 | $5.43M | Buy |
81,332
+46,876
| +136% | +$3.13M | 0.16% | 159 |
|
|
2013
Q3 | $2.16M | Buy |
+34,456
| New | +$2.16M | 0.06% | 326 |
|